News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang
Erika Hamilton and Tian Zhang
Dec 3, 2024, 18:34

Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang

Oncology Brothers shared a post on X:

“Approval is just a start, managing AEs for these matters as much.

Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang.

Listen to the full ‘Oncology Brothers’ Podcast.”

ADCs cancer Erika Hamilton OncoDaily Oncology Oncology Brothers Tian Zhang
Special Coverage
Career
Aug 2, 2025, 11:07
Tilman Krueger Has Been Appointed Director Oncology Policy EU and Pipeline at MSD
Insight
Aug 2, 2025, 11:00
Andres F. Cardona: How Sponsored Clinical Trials Can Generate Economic Value for Healthcare Systems
Blog
Aug 2, 2025, 10:59
Let’s Break the Silence and End Alcohol Harm - Pink Hearts Cancer Support Foundation
Drugs
Aug 2, 2025, 10:49
Emrelis (Telisotuzumab vedotin) Patient Guide 2025: A New Targeted Treatment for Advanced Lung Cancer
Insight
Aug 2, 2025, 10:49
Ramy Sedhom: Away From Reflexive Treatment, Toward Outcomes That Actually Matter
Blog
Aug 2, 2025, 10:43
How an AACR Grant Enabled Madelyn Espinosa-Cotton to Study a Rare and Aggressive Type of Sarcoma
Blog
Aug 2, 2025, 10:20
What is the Main Characteristic of Monoclonal Antibodies? - Servier
Blog
Aug 2, 2025, 10:17
Mohamed Kharfan-Dabaja: Great Update on Management of CD30+ non-Hodgkin Lymphomas
Blog
Aug 2, 2025, 10:14
Got Unpublished Research in EGFRm Lung Cancer? - EGFR Resisters Research Summit
Career
Aug 2, 2025, 10:02
Mohamed A Gouda: Starting a New Role as an Assistant Professor of Medical Oncology at MD Anderson Cancer Center
Blog
Aug 2, 2025, 09:59
James Wu: My 1st Ever Lung Cancer Abstract Won an Conquer Cancer, the ASCO Foundation Merit Award
Blog
Aug 2, 2025, 09:35
Tom Powles: 5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC